Page last updated: 2024-09-02

1-hexadecyl-2-acetyl-glycero-3-phosphocholine and 5,15-dihydroxy-6,8,11,13-eicosatetraenoic acid

1-hexadecyl-2-acetyl-glycero-3-phosphocholine has been researched along with 5,15-dihydroxy-6,8,11,13-eicosatetraenoic acid in 1 studies

Compound Research Comparison

Studies
(1-hexadecyl-2-acetyl-glycero-3-phosphocholine)
Trials
(1-hexadecyl-2-acetyl-glycero-3-phosphocholine)
Recent Studies (post-2010)
(1-hexadecyl-2-acetyl-glycero-3-phosphocholine)
Studies
(5,15-dihydroxy-6,8,11,13-eicosatetraenoic acid)
Trials
(5,15-dihydroxy-6,8,11,13-eicosatetraenoic acid)
Recent Studies (post-2010) (5,15-dihydroxy-6,8,11,13-eicosatetraenoic acid)
9,1561875522603

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Borgeat, P; Braquet, M; Krump, E; McColl, SR; McDonald, PP; Naccache, PH1

Other Studies

1 other study(ies) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and 5,15-dihydroxy-6,8,11,13-eicosatetraenoic acid

ArticleYear
Enhancement of platelet-activating factor-induced leukotriene synthesis in neutrophils by granulocyte-macrophage colony-stimulating factor (GM-CSF): studies on the mechanism of action of GM-CSF.
    Journal of lipid mediators, 1990, Volume: 2 Suppl

    Topics: Arachidonate 5-Lipoxygenase; Arachidonic Acid; Drug Synergism; Granulocyte-Macrophage Colony-Stimulating Factor; Humans; Hydroxyeicosatetraenoic Acids; In Vitro Techniques; Leukotriene B4; Leukotrienes; Lipid Peroxides; Neutrophils; Platelet Activating Factor

1990